Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06422013
Status:
COMPLETED
Last Update Posted:
2024-05-22
First Post:
2024-05-15
Brief Title:
Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1
Sponsor:
Amorepacific Corporation
Organization:
Amorepacific Corporation
Study Overview
Official Title:
A Randomized Double-blind Placebo-controlled Parallel-design Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of Lactiplantibacillus Plantarum APsulloc 331261GTB1
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was conducted to investigate the effects of daily supplementation of GTB1 on decrease of body fat
Detailed Description:
This study was a 12 week randomized double-blind placebo-controlled human trial 100 subjects were randomly divided into GTB1 group and placebo group It is to evaluate the changes in the displayed evaluation items when taking GTB1 once a day in comparison with taking a placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None